Results 21 to 30 of about 48,910 (207)
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention [PDF]
Clinical Infectious Diseases, 2011 Over the past 10 years, dissemination of Klebsiella pneumoniae carbapenemase (KPC) has led to an increase in the prevalence of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Infections caused by CRE have limited treatment options and have been associated with high mortality rates. In the previous year, other carbapenemase subtypes,
Neil, Gupta +3 more
openaire +2 more sources
Carbapenem resistance in the food supply chain
Journal of Food Protection, 2023 Carbapenems are critically important antibiotic agents because they are considered the "last-resort" antibiotics for treating serious infections. However, resistance to carbapenems is increasing throughout the world and has become an urgent problem.
En Huang +3 more
openaire +3 more sources
Carbapenem-Resistant Enterobacteriaceae Infections in Children [PDF]
Current Infectious Disease Reports, 2015 Carbapenem-resistant Enterobacteriaceae (CRE) are an emerging global public health threat. Infections due to CRE are associated with significant morbidity and mortality. Few therapeutic options are available for treatment of these infections, and optimal antibiotic treatment regimens are unclear.
Kathleen, Chiotos +2 more
openaire +2 more sources
Carbapenem-resistant and carbapenem use in Japan: an ecological study
Journal of International Medical Research, 2019 Objective This study focused on carbapenem resistance in Pseudomonas aeruginosa and examined potential ecological correlations with carbapenem use in Japan. Methods The proportion of carbapenem-resistant P.
Fumitaka Terahara, Hiroshi Nishiura
doaj +1 more source
Aminoglycoside-modifying Enzymes in Carbapenem-resistant Pseudomonas aeruginosa Clinical Isolates
Mediterranean Journal of Infection, Microbes and Antimicrobials, 2022 Introduction: Aminoglycosides are the drug of choice for the treatment of Pseudomonas aeruginosa infections. Aminoglycoside resistance in P. aeruginosa often occurred via acquired aminoglycoside-modifying enzymes (AMEs).
Yeliz TANRIVERDİ ÇAYCI +6 more
doaj +1 more source
Journal of Nepal Health Research Council, 2021 Background: Non-fermentative Gram-negative bacilli or non-fermenters are opportunistic pathogens associated with serious infections in intensive care unit patients.
Santosh Kumar Yadav +4 more
doaj +1 more source
Scientific Reports, 2023 Carbapenem antibiotics are widely used in ICU, and the prevalence of carbapenem-resistant microorganisms (CRO) has increased. This study aimed to assess the role of individualized active surveillance using Xpert Carba-R of carbapenem resistance genes on ...
Shuliang Zhou +7 more
doaj +1 more source
Synergistic Activity of Equol and Meropenem against Carbapenem-Resistant Escherichia coli
Antibiotics, 2021 The emergence of carbapenem-resistant Enterobacterales (CRE) seriously limits treatment options for bacterial infections. Combined drugs are an effective strategy to treat these resistant strains.
Hye-Rim Kim, Yong-Bin Eom
doaj +1 more source
Environmental Contamination by Carbapenem-Resistant Enterobacteriaceae [PDF]
Journal of Clinical Microbiology, 2013 ABSTRACT In the last decade, the global emergence of carbapenem resistance in Enterobacteriaceae has posed great concern to public health. Data concerning the role of environmental contamination in the dissemination of carbapenem-resistant Enterobacteriaceae (CRE) are currently ...
Lerner, A. +5 more
openaire +2 more sources
Frontiers in Cellular and Infection Microbiology, 2023 BackgroundNearly 30% of patients infected with carbapenem-resistant Klebsiella pneumoniae (CRKP) were previously shown to be coinfected with carbapenem-resistant Pseudomonas aeruginosa (CRPA) or Acinetobacter baumannii (CRAB).
Anthony Sophonsri +6 more
doaj +1 more source